New software to capture worldwide cancer data

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from Queen’s University Belfast, the Northern Ireland Cancer Registry, the International Agency for Research on Cancer and the Union for International Cancer Control have developed CanStaging+, a user-friendly tool aimed at facilitating the recording of comparable cancer staging data worldwide.

The collection of staging data at population-level is currently undertaken by population-based cancer registries. There is a large variation of data collected making it difficult to benchmark and to develop global strategies.

“Almost half of registries in Latin America and the Caribbean (52%) report staging information compared to 96% of registries in North America and Europe,” said Anna Gavin, who led the work from the Northern Ireland Cancer registry Centre for Public Health at Queen’s University Belfast.

A lack of data and inconsistency is a huge problem in high-income countries too where there were 6-37% of missing staging data for colorectal cancer across seven countries within the International Cancer Benchmarking Partnership between 2010 and 2014.

To mark the launch of the CanStaging+ tool, an accompanying article has been published in The Lancet Oncology.

Table of Contents

YOU MAY BE INTERESTED IN

If you listen to GRAIL executives discuss the results of the long-awaited trial of the company’s multicancer detection test, you might be led to conclude that the company’s pivotal NHS-Galleri study had an overwhelmingly positive result.
Undeterred by the negative topline result of its pivotal trial of Galleri, a multicancer detection test, the test’s sponsor, GRAIL, said it’s forging ahead with its plan to get FDA approval and reimbursement from CMS and private insurers.
Philip E. Castle, director of the NCI Division of Cancer Prevention, said he was disappointed to hear that GRAIL’s NHS-Galleri trial did not meet its primary endpoint of reduction in late-stage cancers.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login